Merck (MRK) Long-Term Deferred Tax (2010 - 2023)

Merck (MRK) has reported Long-Term Deferred Tax for 14 consecutive years, with $10.2 billion the latest figure, recorded in Q2 2023.

• On a quarterly basis, Long-Term Deferred Tax fell 7.15% year-over-year to $10.2 billion in Q2 2023; TTM through Jun 2023 was $10.2 billion, a 7.15% decrease from a year earlier, with the FY2022 full-year figure at $9.5 billion, down 17.73% from the prior year.
• Long-Term Deferred Tax was $10.2 billion for Q2 2023 at Merck, down from $10.3 billion in the prior quarter.
• Over five years, Long-Term Deferred Tax peaked at $11.6 billion in Q4 2021 and troughed at $6.8 billion in Q4 2019.
• A 5-year average of $9.6 billion and a median of $9.7 billion in 2020 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax retreated 19.01% in 2020 and jumped 48.7% in 2021, its largest moves.
• Over 5 years, Long-Term Deferred Tax stood at $6.8 billion in 2019, then surged by 45.93% to $9.9 billion in 2020, then advanced by 17.21% to $11.6 billion in 2021, then retreated by 17.73% to $9.5 billion in 2022, then gained by 6.92% to $10.2 billion in 2023.
• The last three Long-Term Deferred Tax figures came in at $10.2 billion (Q2 2023), $10.3 billion (Q1 2023), and $9.5 billion (Q4 2022), per Business Quant data.